108
Participants
Start Date
April 15, 2025
Primary Completion Date
October 31, 2027
Study Completion Date
December 31, 2027
NRT6003 Injection
Patients will be administered NRT6003 Injection via Intra-arterial infusion, and subsequently they will be assessed by PET/CT imaging within 24 hours for its distribution in the chest and upper abdomen, including extrahepatic shunts, intrahepatic distribution, and target lesion distribution as expected.
cTACE
Patients will receive cTACE treatment. And the investigators will select one or more chemotherapy drugs in combination with embolic materials for administration, based on the specific condition of the patient.
RECRUITING
Zhongda Hospital Southeast University, Nanjing
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou
RECRUITING
The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
RECRUITING
Zhongnan Hospital of Wuhan University, Wuhan
RECRUITING
The First Hospital of China Medical University, Shenyang
RECRUITING
West China Hospital, Chengdu
RECRUITING
Tianjin Cancer Hospital Airport Hospital, Tianjin
Chengdu New Radiomedicine Technology Co. LTD.
INDUSTRY